Structural basis of interaction between the hepatitis C virus p7 channel and its blocker hexamethylene amiloride
Published date: 09 May 2016
Copyright
Linlin Zhao , Shuqing Wang , Lingyu Du , Jyoti Dev , Liujuan Zhou , Zhijun Liu , James J. Chou , Bo OuYang . Structural basis of interaction between the hepatitis C virus p7 channel and its blocker hexamethylene amiloride[J]. Protein & Cell, 2016 , 7(4) : 300 -304 . DOI: 10.1007/s13238-016-0256-7
1 |
Cook GA, Dawson LA, Tian Y, Opella SJ (2013) Three-dimensional structure and interaction studies of hepatitis C virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance. Biochemistry 52:5295–5303
|
2 |
DassaultSystèmesBIOVIA (2015) Discovery studio modeling environment. Dassault Systèmes, San Diego
|
3 |
Dev J, Bruschweiler S, Ouyang B, Chou JJ (2015) Transverse relaxation dispersion of the p7 membrane channel from hepatitis C virus reveals conformational breathing. J Biomol NMR 61:369–378
|
4 |
Foster TL, Verow M, Wozniak AL, Bentham MJ, Thompson J, Atkins E, Weinman SA, Fishwick C, Foster R, Harris M
|
5 |
Foster TL, Thompson GS, Kalverda AP, Kankanala J, Bentham M, Wetherill LF, Thompson J, Barker AM, Clarke D, Noerenberg M
|
6 |
Griffin SD, Beales LP, Clarke DS, Worsfold O, Evans SD, Jaeger J, Harris MP, Rowlands DJ (2003) The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535:34–38
|
7 |
Griffin S, Stgelais C, Owsianka AM, Patel AH, Rowlands D, Harris M (2008) Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology 48:1779–1790
|
8 |
Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41–52
|
9 |
Li H, Atkins E, Bruckner J, McArdle S, Qiu WC, Thomassen LV, Scott J, Shuhart MC, Livingston S, Townshend-Bulson L
|
10 |
Luscombe CA, Huang Z, Murray MG, Miller M, Wilkinson J, Ewart GD (2010) A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues. Antiviral Res 86:144–153
|
11 |
Moradpour D, Penin F (2013) Hepatitis C virus proteins: from structure to function. Curr Top Microbiol Immunol 369:113–142
|
12 |
OuYang B, Xie S, Berardi MJ, Zhao X, Dev J, Yu W, Sun B, Chou JJ (2013) Unusual architecture of the p7 channel from hepatitis C virus. Nature 498:521–525
|
13 |
Pavlovic D, Fischer W, Hussey M, Durantel D, Durantel S, Branza-Nichita N, Woodhouse S, Dwek RA, Zitzmann N (2005) Long alkylchain iminosugars block the HCV p7 ion channel. Adv Exp Med Biol 564:3–4
|
14 |
Pielak RM, Oxenoid K, Chou JJ (2011) Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses. Structure 19:1655–1663.
|
15 |
Premkumar A, Wilson L, Ewart GD, Gage PW (2004) Cationselective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride. FEBS Lett 557:99–103
|
/
〈 | 〉 |